Tag: Andexanet alfa

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Andexanet alfa

Analysts See $-0.71 EPS for Imperva, Inc. (IMPV); Portola Pharmaceuticals (PTLA) Has 0.89 ...

Added to Collection on: 2018-07-24 18:18:45

Tags for this article:

Computing
Internet
NASDAQ
Computer security
Internet security
Firewall software
Imperva
Betrixaban
Andexanet alfa
ELLIOTT REDUCED IMPV
Portola Valley, California

Click the tags to see associated articles and topics

View Article Details
Portola Pharmaceuticals, Inc. (PTLA) Reaches $34.01 After 5.00% Up Move; Bp Wealth ...

Added to Collection on: 2019-02-28 23:56:15

Tags for this article:

United States
NASDAQ
Private equity
Arm Holdings
NXP Semiconductors
Eindhoven
Betrixaban
Companies
Andexanet alfa
Anticoagulant
Portola Pharmaceuticals
Cerdulatinib

Click the tags to see associated articles and topics

View Article Details
Gottlieb to Resign as FDA Commissioner, Ending Tenure Marked by Record-High Drug Approvals

Added to Collection on: 2019-03-05 05:11:15

Tags for this article:

Health
Food and Drug Administration
Center for Drug Evaluation and Research
Scott Gottlieb
Biopharmaceutical
Life Sciences
Andexanet alfa
New Drug Application
Portola Pharmaceuticals
Center for Biologics Evaluation and Research
PEGylation
Alex Azar II

Click the tags to see associated articles and topics

View Article Details
NICE backs restricted use of Ondexxya

Added to Collection on: 2021-04-06 08:48:45

Tags for this article:

Clinical medicine
Chemical compounds
Blood
Coagulation system
Antidotes
Apixaban
Bristol-Myers Squibb
Lactams
Piperidines
Andexanet alfa
Anticoagulant
Rivaroxaban

Click the tags to see associated articles and topics

View Article Details
Asia Pacific Anticoagulant Reversal Drug Market Growth and Trends to 2020-2027 With Top ...

Added to Collection on: 2021-06-16 04:52:30

Tags for this article:

Clinical medicine
Health sciences
Medicine
Boehringer Ingelheim
Antidotes
Blood tests
Anticoagulant
Direct thrombin inhibitors
Dabigatran
Pharmaceutical industry in China
Andexanet alfa
Antiphospholipid syndrome

Click the tags to see associated articles and topics

View Article Details
Global Anticoagulant Reversal Drugs Market to Surpass US$ 3089.2 Million by 2028, Says ...

Added to Collection on: 2021-08-06 12:45:00

Tags for this article:

Health sciences
Health care
Life Sciences
Antidotes
Andexanet alfa
Alexion Pharmaceuticals
Pharmaceutical industry
Anticoagulant
Portola Pharmaceuticals
Rivaroxaban
Direct factor Xa inhibitors
Pharmaceutical industry in China

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Ondexxya gets approval in Japan to reverse effect of anti blood clot drugs

Added to Collection on: 2022-03-29 09:19:33

Tags for this article:

Chemical compounds
Organic compounds
Clinical medicine
Antidotes
Chloroarenes
Andexanet alfa
Coagulation system
Apixaban
Anticoagulant
Rivaroxaban
Discovery and development of direct Xa inhibitors
Portola Pharmaceuticals
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Ondexxya approved in Japan to treat major bleeds - Morningstar

Added to Collection on: 2022-03-29 08:14:15

Tags for this article:

Medicine
Clinical medicine
Life Sciences
Andexanet alfa
Antidotes
Anticoagulants
Coagulation system
Factor X
Direct factor Xa inhibitors
AstraZeneca
Oxford–AstraZeneca COVID-19 vaccine
Portola Pharmaceuticals
AstraZeneca plc
Japan

Click the tags to see associated articles and topics

View Article Details
AstraZeneca Ondexxya approved in Japan - UK Investor Magazine

Added to Collection on: 2022-03-29 07:55:52

Tags for this article:

Chemical compounds
Organic compounds
Chloroarenes
Antidotes
Coagulation system
Andexanet alfa
Apixaban
Rivaroxaban
Anticoagulant
Factor X
Coagulation
Edoxaban
Japan

Click the tags to see associated articles and topics

View Article Details
AstraZeneca receives CDSCO approval to import, market Andexanet Alfa in India

Added to Collection on: 2024-01-23 14:58:35

Tags for this article:

Antidotes
Andexanet alfa
Anticoagulant
Apixaban
Rivaroxaban
AstraZeneca
Direct factor Xa inhibitors
Oxford–AstraZeneca COVID-19 vaccine
Atrial fibrillation
Central Drugs Standard Control Organisation
Stroke
Coagulation
AstraZeneca Pharma India Ltd
India

Click the tags to see associated articles and topics

View Article Details